Clinical Guidelines for Drug-induced Peptic Ulcer, 2020 Revised Edition
10.4166/kjg.2020.76.3.108
- Author:
Moon Kyung JOO
1
;
Chan Hyuk PARK
;
Joon Sung KIM
;
Jae Myung PARK
;
Ji Yong AHN
;
Bong Eun LEE
;
Jeong Hoon LEE
;
Hyo-Joon YANG
;
Yu Kyung CHO
;
Chang Seok BANG
;
Beom Jin KIM
;
Hye-Kyung JUNG
;
Byung-Wook KIM
;
Yong Chan LEE
;
Author Information
1. Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea
- Publication Type:Review Article
- From:The Korean Journal of Gastroenterology
2020;76(3):108-133
- CountryRepublic of Korea
-
Abstract:
The Korean guidelines for nonsteroidal anti-inflammatory drug (NSAID)-induced peptic ulcers were previously developed under co-work with the Korean College of Helicobacter and Upper Gastrointestinal Research and Korean Society of Gastroenterology at 2009. On the other hand, the previous guidelines were based mainly on a literature review and expert opinions. Therefore, the guidelines need to be revised. In this study, a guideline development committee for drug-induced peptic ulcers was organized under the Korean College of Helicobacter and Upper Gastrointestinal Research in 2017. Nine statements were developed, including four for NSAID, three for aspirin and other antiplatelet agents, and two for anticoagulants through de novo processes based on evidence-based medicine, such as a literature search, meta-analysis, and the consensus was established using the modified Delphi method. The primary target of this guideline was adult patients taking long-term NSAIDs, aspirin, or other antiplatelet agent and anticoagulants. The revised guidelines reflect the consensus of expert opinions and are intended to assist relevant clinicians in the management and prevention of drug-induced peptic ulcers and associated conditions.
